US biotech BioXcel Therapeutics hopes to use wearable digital devices such as the Apple Watch to predict whether patients with Alzheimer’s are becoming agitated, so that the company’s devel
After trial failure upon trial failure in Alzheimer's disease will big pharma be prepared to fund a trial using a new approach instead of the amyloid-targeting drugs, that have caused so mu
Oxford Brain Diagnostic’s Dr Steven Chance explains the importance of early detection of dementia for treatment and research, and why new measurements of neurodegeneration are needed.
A blood test could be used to diagnose Alzheimer’s before symptoms arise, providing an alternative to expensive brain scans and speeding up recruitment to badly-needed clinical trials.
